Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04388215

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04388215
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04388215. Randomized; quadruple masking; primary purpose treatment. Start 2019-10-23 (actual); primary completion 2021-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet
Condition
Hypertension
Condition
Dyslipidemias
Intervention (Drug)
CKD-828
Intervention (Drug)
CKD-828(placebo)
Intervention (Drug)
D326
Intervention (Drug)
D326(placebo)
Intervention (Drug)
D337
Intervention (Drug)
D337(placebo)
Intervention (Drug)
D013
Intervention (Drug)
D013(placebo)
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct04388215
Content hash
bf10fc26bb97191526db6b2a0992aa6a1d910e1d3ff6a36e16f02c495bcb7912